NPS PHARMACEUTICALS INC
10-Q, EX-27.1, 2000-11-14
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: NPS PHARMACEUTICALS INC, 10-Q, 2000-11-14
Next: REVLON CONSUMER PRODUCTS CORP, 10-Q, 2000-11-14



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JUL-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                      23,312,000
<SECURITIES>                                49,462,000
<RECEIVABLES>                                  645,000
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                            74,520,000
<PP&E>                                      12,289,000
<DEPRECIATION>                               6,817,000
<TOTAL-ASSETS>                              96,545,000
<CURRENT-LIABILITIES>                        4,834,000
<BONDS>                                              0
                                0
                                          0
<COMMON>                                        25,000
<OTHER-SE>                                  90,063,000
<TOTAL-LIABILITY-AND-EQUITY>                96,545,000
<SALES>                                              0
<TOTAL-REVENUES>                             2,923,000
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                            10,279,000
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              27,000
<INCOME-PRETAX>                            (7,383,000)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (7,383,000)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (7,383,000)
<EPS-BASIC>                                     (0.30)
<EPS-DILUTED>                                   (0.30)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission